Skip to main content

Affy to Collaborate with Qiagen/BD Joint Venture on Whole Blood Expression Profiling

NEW YORK, Oct. 31 (GenomeWeb News) - Affymetrix and Hombrechtikon, Switzerland-based PreAnalytix said today that they have decided to collaborate to use PreAnalytix's Blood RNA System with Affy's GeneChip arrays to analyze whole blood for expression profiling. PreAnalytix is a joint venture between Qiagen and BD.

 

The non-exclusive agreement will have as its goal a reduction in the variability in the preparation processes involved with screening whole blood samples, and a reduction in the signal contributed by globin RNA when analyzing whole blood.

 

PreAnalytix makes evacuated blood collection tubes for stabilizing whole blood cellular RNA profiles at the time of blood collection.

 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.